AKT1 and lung cancer: For example, in lung cancer cells (A549 and H1651), metformin-activated PP2A reduced tumor formation in vivo and decreased tumor cell growth and invasion capacity in vitro as well as serine phosphorylation level of Bax (Ser184), Myc (Ser62), and Akt (Ser473) [23].